75541666 - PROTOMASC

Information

  • Trademark
  • 75541666
  • Serial Number
    75541666
  • Filing Date
    August 21, 1998
    27 years ago
  • Transaction Date
    May 10, 2008
    17 years ago
  • Status Date
    October 24, 2002
    23 years ago
  • Published for Opposition Date
    July 31, 2001
    24 years ago
  • Location Date
    June 09, 2003
    22 years ago
  • Status Code
    606
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    CHARLON, BARNEY LAWREN
  • Attorney Name
    Donna J. Bunton
    Law Office Assigned Location Code
    L50
  • Owners
Mark Drawing Code
1000
Mark Identification
PROTOMASC
Case File Statements
  • GS0011: POLYMER DERIVATIVES AND POLYETHYLENE GLYCO DERIVATIVES FOR USE IN THE MANUFACTURE LIPOSOMES TO BE USED AS THERAPEUTICS, DIAGNOSTICS, AND IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF COSMETIC AND PHARMACEUTICAL PREPARATIONS AND SUBSTANCES; POLYMER BEADS FOR USE IN MANUFACTURING; POLYALKYLENE GLYCOLS FOR USE IN THE MANUFACTURE OF LIPOSOMES TO BE USED AS THERAPEUTICS DIAGNOSTICS, AND AS IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; LIPOSOMES FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS; DIAGNOSTIC AGENTS AND REAGENTS FOR MEDICAL RESEARCH USE; POLYMER MODIFIED COMPOUNDS FOR USE IN THE MANUFACTURE OF CARRIERS FOR THERAPEUTIC AND DIAGNOSTIC AGENTS-3-
  • GS0031: COSMETIC AND TOILETRY PRODUCTS CONTAINING POLYMER DERIVATIVES; NAMELY, EAU DE COLOGNE, PERFUMES, SHAVING SOAP, TALCUM POWDER, DENTIFRICES, TOOTHPASTE, ESSENTIAL OILS FOR PERSONAL USE, BATH OILS AND BATH SALTS, DEODORANTS FOR PERSONAL USE, SKIN SOAPS, SKIN CREAMS AND SKIN LOTIONS, SKIN MOISTURIZING CREAMS, BODY LOTIONS, AFTERSHAVE, LIPSTICK, MASCARA, EYELINER, SKIN CLEANSERS, MAKE-UP POWDERS AND CREAMS; NAIL POLISH; HAIRCARE PRODUCTS, NAMELY, HAIR SHAMPOO, CONDITIONER AND GEL; HAIR COLORANTS AND HAIR SPRAYS; MOUSSES AND BALMS FOR HAIR STYLING AND HAIR CARE
  • GS0051: PHARMACEUTICAL AND VETERINARY PREPARATIONS AND SUBSTANCES; NAMELY, PROTEINS, PEPTIDES, AMINO ACIDS AND THEIR DERIVATIVES, NAMELY, ANTIBODIES AND FRAGMENTS THEREOF; CYTOKINES AND DERIVATIVES OR FRAGMENTS THEREOF, NAMELY, THE INTERLEUKINS IL, ESPECIALLY THE IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10 AND IL-11 SUBTYPES THEREOF; COLONY STIMULATING FACTORS, NAMELY, GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR, GRANULOCYTE-COLONYSTIMULATING FACTOR, ALPHA AND BETA FORMS, AND MACROPHAGE-COLONY STIMULATING FACTOR, ALSO KNOWN AS CSF-1; HAEMOPOIETINS, NAMELY, ERYTHROPOIETIN, HAEMOPOIETIN-ALPHA AND KIT-LIGAND, ALSO KNOWN AS STEM CELL FACTOR OR STEEL FACTOR; INTERFERONS IFNS, NAMELY, IFNALPHA, IFNBETA, IFNGAMMA; GROWTH FACTORS AND BIFUNCTIONAL GROWTH MODULATORS, NAMELY, EPIDERMAL GROWTH FACTOR, PLATELET-DERIVED GROWTH FACTOR, TRANSFORMING GROWTH FACTOR, ALPHA AND BETA FORMS, AMPHIREGULIN, SOMATOMEDIN-C, BONE GROWTH FACTOR, FIBROBLAST GROWTH FACTORS, INSULIN-LIKE GROWTH FACTORS, HERAPIN BINDING GROWTH FACTORS AND TUMOR GROWTH FACTORS; DIFFERENTIATION FACTORS AND THE LIKE, NAMELY, MACROPHAGE DIFFERENTIATING FACTOR, DIFFERENTIATION INDUCING FACTOR DIF AND LEUKAEMIA INHIBITORY FACTOR; ACTIVATING FACTORS, NAMELY, PLATELET ACTIVATING FACTOR; COAGULATION FACTORS SUCH AS FIBRINOLYTIC/ANTICOAGULANT AGENTS INCLUDING HERAPIN AND PROTEASES AND THEIR PRO-FACTORS, NAMELY, CLOTTING FACTORS VII, VIII, IX, X, Xl, XII, ANTITHROMBIN Ill, PROTEIN C, PROTEIN S, STREPTOKINASE, UROKINASE, PROUROKINASE, TISSUE PLASMINOGEN ACTIVATOR, FIBRINOGEN AND HIRUDIN; PEPTIDE HORMONES, NAMELY, INSULIN AND CALCITONIN; ENZYMES NAMELY, SUPEROXIDE DISMUTASE, GLUCOCEREBROSIDASE, ASPARAGINASE AND ADENOSINE DEAMINASE; TRANSCRIPTION FACTORS AND TRANSCRIPTIONAL MODULATORS
  • GS0101: CATHETERS; STENTS AND PARTS AND FITTINGS FOR THESE GOODS
  • GS0351: TECHNOLOGY LICENSING SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY
  • GS0421: RESEARCH AND CONSULTANCY SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY
Case File Event Statements
  • 6/5/2003 - 22 years ago
    14 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 5/1/2002 - 23 years ago
    13 - EXTENSION 1 GRANTED Type: EX1G
  • 4/19/2002 - 23 years ago
    12 - EXTENSION 1 FILED Type: EXT1
  • 10/23/2001 - 24 years ago
    11 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/31/2001 - 24 years ago
    10 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/18/2001 - 24 years ago
    9 - NOTICE OF PUBLICATION Type: NPUB
  • 2/26/2001 - 25 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/1/2001 - 25 years ago
    7 - EXAMINER'S AMENDMENT MAILED Type: CNEA
  • 6/20/2000 - 25 years ago
    6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/9/2000 - 25 years ago
    5 - CONTINUATION OF FINAL REFUSAL MAILED Type: CNCF
  • 1/5/2000 - 26 years ago
    4 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/20/1999 - 26 years ago
    3 - FINAL REFUSAL MAILED Type: CNFR
  • 9/1/1999 - 26 years ago
    2 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/1/1999 - 27 years ago
    1 - NON-FINAL ACTION MAILED Type: CNRT